![]() HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | ||||
Founding Date | Founding Date 2003 | Founding Date 2001 | Founding Date 2020 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Boston, US HQ | Locations Rockville, US HQ Hangzhou, CN |
Employees | Employees 58 | Employees 811% decrease | Employees 31 | Employees 303% decrease |
Financial | ||||
Net income | Net income (£14.9m) (FY, 2025) | Net income N/A | Net income ($147.3m) (FY, 2024) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 3.9m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 95.9m (over 5 years ago) |
Total funding raised | Total funding raised $ 66.8m | Total funding raised $ 41.5m | Total funding raised N/A | Total funding raised $ 95.9m |

Domain Therapeutics is a biopharmaceutical company.
View company
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
View company
Innoforce Pharmaceuticals is a company operating a biotech operation park.
View company